Tags : Fast Acting Insulin Lispro

Eli Lilly’s Fast-Acting Insulin Lispro Receives CHMP’s Positive Opinion in

Tuba Khan January 31, 2020

Shots: The approval is based on two studies, PRONTO-T1D & PRONTO-T2D assessing fast-acting insulin lispro (URLi) vs Humalog both in combination with insulin glargine/ degludec in 1,222 & 673 patients […]readmore

Tags : Fast Acting Insulin Lispro

Eli Lilly’s Fast-Acting Insulin Lispro Receives CHMP’s Positive Opinion in

Latest Posts

PharmaShots Weekly Snapshots (November 15 – 19, 2021)

Jazz’ Sunosi (solriamfetol) Receives NICE Recommendation for the Treatment of Excessive Daytime Sleepiness Caused by Narcolepsy

Antengene’s Selinexor (ATG-010) Receives NMPA’s IND Approval for P-I/II SWATCH Study to Treat Non-Hodgkin Lymphoma

Daiichi Sankyo Reports Results of Quizartinib in P-III QuANTUM-First Trial for the Treatment of FLT3-ITD Positive AML

Company

Tags : Fast Acting Insulin Lispro

Eli Lilly’s Fast-Acting Insulin Lispro Receives CHMP’s Positive Opinion in

Latest Posts

PharmaShots Weekly Snapshots (November 15 – 19, 2021)

Jazz’ Sunosi (solriamfetol) Receives NICE Recommendation for the Treatment of Excessive Daytime Sleepiness Caused by Narcolepsy

Antengene’s Selinexor (ATG-010) Receives NMPA’s IND Approval for P-I/II SWATCH Study to Treat Non-Hodgkin Lymphoma

Daiichi Sankyo Reports Results of Quizartinib in P-III QuANTUM-First Trial for the Treatment of FLT3-ITD Positive AML

Categories

Related Topics

Company